Cadus Corporation focuses on real estate acquisition, renovation, and construction activities in Florida. As of March 15, 2015, the company had purchased and continues to own 12 single-family residential zoned properties in Miami-Dade County, Florida. The lots for these properties range from approximately 7,500 to approximately 18,400 square feet, with an average lot size of approximately 15,000 square feet and with most of the lots having an area of approximately 12,000 square feet. When individual homes are purchased, the company intends, as appropriate, to renovate them for resale or to demolish them for new home construction. When vacant lots are purchased, the company intends to construct new homes on them for sale. In some cases, the company might also acquire partially constructed or renovated homes for completion and resale or resell acquired homes or land without undertaking renovation or construction. The company has a wholly owned subsidiary, Cadus Technologies, Inc. (Cadus Technologies), which holds all patents, patent applications, know how, licenses and drug discovery technologies of the company. As of March 1, 2015, Cadus Technologies is the assignee of 16 issued U.S. patents covering aspects of its yeast technology and is the exclusive worldwide licensee of one issued U.S. patent for use in drug discovery. History The company was founded in 1992. It was incorporated under the laws of the state of Delaware in 1992. The company was formerly known as Cadus Pharmaceutical Corporation and changed its name to Cadus Corporation in 2003.
cadus corp (KDUS:OTC BB)
767 Fifth Avenue
New York, NY 10153
|No competitor information is available for KDUS.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact CADUS CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.